BRO vs CDTX · P/E 30, rev $4.80B vs rev $1.3M
Brown & Brown Inc (BRO) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the BRO and CDTX stock pages for the full models.
Not investment advice.